Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Oct;81(3):510–519. doi: 10.1038/sj.bjc.6690723

Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients

B Werle 1, H Lötterle 1, U Schanzenbächer 1, T T Lah 5, E Kalman 6, K Kayser 2, H Bülzebruck 3, J Schirren 4, M Krasovec 7, J Kos 7,8, E Spiess 9
PMCID: PMC2362911  PMID: 10507778

Abstract

In order to evaluate the possible role of the proteolytic enzyme cathepsin B (cath B) in human non-small cell lung cancer (NSCLC) we examined cath B concentrations (cath Bc) and activities (cath BA) in homogenates of 127 pairs of lung tumour tissues and corresponding non-tumourous lung parenchyma. Total cath B activity (cath BAT) and enzymatic activity of the fraction of cath B, which is stable and active at pH 7.5 (cath BA7.5) were determined by a fluorogenic assay using synthetic substrate Z-Arg-Arg-AMC. The immunostaining pattern of cath B was determined in 239 lung tumour tissue sections, showing the presence of the enzyme in tumour cells (cath BT-I) and in tumour-associated histiocytes (cath BH-I). The median levels of cath BAT, cath BA7.5 and cath BC were 5.6-, 3.2- and 9.1-fold higher (P < 0.001), respectively, in tumour tissue than in non-tumourous lung parenchyma. Out of 131 tissue sections from patients with squamous cell carcinoma (SCC), 59.5% immunostained positively for cath B, while among the 108 adenocarcinoma (AC) patients 48.2% of tumours showed a positive reaction. There was a strong relationship between the levels of cath BAT, cath BA7.5, cath BC and cath BT-I in the primary tumours and the presence of lymph node metastases. Significant correlation with overall survival was observed for cath BT-I and cath BA7.5 (P < 0.01 and P < 0.05, respectively) in patients suffering from SCC. In these patients positive cath B in tumour cells (cath BT-I) and negative cath B in histiocytes (cath BH-I) indicated significantly shorter survival rate compared with patients with negative cath BT-I and positive cath BH-I (P < 0.0001). In contrast, in AC patients, both, positive cath BT-I and positive cath BH-I, indicated poor survival probability (P < 0.014). From these results we conclude that the proteolytic enzyme cath B is an independent prognostic factor for overall survival of patients suffering from SCC of the lung. © 1999 Cancer Research Campaign

Keywords: cathepsin B, prognosis, non-small cell lung cancer, squamous cell carcinoma

Full Text

The Full Text of this article is available as a PDF (268.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abel U., Berger J., Wiebelt H. CRITLEVEL: an exploratory procedure for the evaluation of quantitative prognostic factors. Methods Inf Med. 1984 Jul;23(3):154–156. [PubMed] [Google Scholar]
  2. Bandlow G., Härtl R. Selection and isolation of a new variant of DBA/2 mastocytoma P 815 X 2. J Cancer Res Clin Oncol. 1989;115(6):550–553. doi: 10.1007/BF00391356. [DOI] [PubMed] [Google Scholar]
  3. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  4. Budihna M., Strojan P., Smid L., Skrk J., Vrhovec I., Zupevc A., Rudolf Z., Zargi M., Krasovec M., Svetic B. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma. Biol Chem Hoppe Seyler. 1996 Jun;377(6):385–390. doi: 10.1515/bchm3.1996.377.6.385. [DOI] [PubMed] [Google Scholar]
  5. Calkins C. C., Sloane B. F. Mammalian cysteine protease inhibitors: biochemical properties and possible roles in tumor progression. Biol Chem Hoppe Seyler. 1995 Feb;376(2):71–80. [PubMed] [Google Scholar]
  6. Castiglioni T., Merino M. J., Elsner B., Lah T. T., Sloane B. F., Emmert-Buck M. R. Immunohistochemical analysis of cathepsins D, B, and L in human breast cancer. Hum Pathol. 1994 Sep;25(9):857–862. doi: 10.1016/0046-8177(94)90003-5. [DOI] [PubMed] [Google Scholar]
  7. Ebert W., Knoch H., Werle B., Trefz G., Muley T., Spiess E. Prognostic value of increased lung tumor tissue cathepsin B. Anticancer Res. 1994 May-Jun;14(3A):895–899. [PubMed] [Google Scholar]
  8. Emmert-Buck M. R., Roth M. J., Zhuang Z., Campo E., Rozhin J., Sloane B. F., Liotta L. A., Stetler-Stevenson W. G. Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol. 1994 Dec;145(6):1285–1290. [PMC free article] [PubMed] [Google Scholar]
  9. Erdel M., Trefz G., Spiess E., Habermaas S., Spring H., Lah T., Ebert W. Localization of cathepsin B in two human lung cancer cell lines. J Histochem Cytochem. 1990 Sep;38(9):1313–1321. doi: 10.1177/38.9.2201737. [DOI] [PubMed] [Google Scholar]
  10. Fidler I. J. Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages. Cancer Res. 1974 May;34(5):1074–1078. [PubMed] [Google Scholar]
  11. Higashiyama M., Doi O., Kodama K., Yokouchi H., Tateishi R. Cathepsin B expression in tumour cells and laminin distribution in pulmonary adenocarcinoma. J Clin Pathol. 1993 Jan;46(1):18–22. doi: 10.1136/jcp.46.1.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Honn K. V., Timár J., Rozhin J., Bazaz R., Sameni M., Ziegler G., Sloane B. F. A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. Exp Cell Res. 1994 Sep;214(1):120–130. doi: 10.1006/excr.1994.1240. [DOI] [PubMed] [Google Scholar]
  13. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  14. Hughes S. J., Glover T. W., Zhu X. X., Kuick R., Thoraval D., Orringer M. B., Beer D. G., Hanash S. A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma. Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12410–12415. doi: 10.1073/pnas.95.21.12410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Inoue T., Ishida T., Sugio K., Sugimachi K. Cathepsin B expression and laminin degradation as factors influencing prognosis of surgically treated patients with lung adenocarcinoma. Cancer Res. 1994 Dec 1;54(23):6133–6136. [PubMed] [Google Scholar]
  16. Kos J., Nielsen H. J., Krasovec M., Christensen I. J., Cimerman N., Stephens R. W., Brünner N. Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. Clin Cancer Res. 1998 Jun;4(6):1511–1516. [PubMed] [Google Scholar]
  17. Kos J., Smid A., Krasovec M., Svetic B., Lenarcic B., Vrhovec I., Skrk J., Turk V. Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer. Biol Chem Hoppe Seyler. 1995 Jul;376(7):401–405. doi: 10.1515/bchm3.1995.376.7.401. [DOI] [PubMed] [Google Scholar]
  18. Kos J., Stabuc B., Schweiger A., Krasovec M., Cimerman N., Kopitar-Jerala N., Vrhovec I. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res. 1997 Oct;3(10):1815–1822. [PubMed] [Google Scholar]
  19. Krepela E., Kasafírek E., Novák K., Viklický J. Increased cathepsin B activity in human lung tumors. Neoplasma. 1990;37(1):61–70. [PubMed] [Google Scholar]
  20. Lah T. T., Calaf G., Kalman E., Shinde B. G., Russo J., Jarosz D., Zabrecky J., Somers R., Daskal I. Cathepsins D, B and L in breast carcinoma and in transformed human breast epithelial cells (HBEC). Biol Chem Hoppe Seyler. 1995 Jun;376(6):357–363. doi: 10.1515/bchm3.1995.376.6.357. [DOI] [PubMed] [Google Scholar]
  21. Lah T. T., Hawley M., Rock K. L., Goldberg A. L. Gamma-interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophages. FEBS Lett. 1995 Apr 17;363(1-2):85–89. doi: 10.1016/0014-5793(95)00287-j. [DOI] [PubMed] [Google Scholar]
  22. Lah T. T., Kokalj-Kunovar M., Strukelj B., Pungercar J., Barlic-Maganja D., Drobnic-Kosorok M., Kastelic L., Babnik J., Golouh R., Turk V. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma. Int J Cancer. 1992 Jan 2;50(1):36–44. doi: 10.1002/ijc.2910500109. [DOI] [PubMed] [Google Scholar]
  23. Lah T. T., Kos J. Cysteine proteinases in cancer progression and their clinical relevance for prognosis. Biol Chem. 1998 Feb;379(2):125–130. [PubMed] [Google Scholar]
  24. Ledakis P., Tester W. T., Rosenberg N., Romero-Fischmann D., Daskal I., Lah T. T. Cathepsins D, B, and L in malignant human lung tissue. Clin Cancer Res. 1996 Mar;2(3):561–568. [PubMed] [Google Scholar]
  25. Leto G., Tumminello F. M., Pizzolanti G., Montalto G., Soresi M., Carroccio A., Ippolito S., Gebbia N. Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis. Pancreas. 1997 Jan;14(1):22–27. doi: 10.1097/00006676-199701000-00004. [DOI] [PubMed] [Google Scholar]
  26. Mantovani A. Tumor-associated macrophages. Curr Opin Immunol. 1989;2(5):689–692. doi: 10.1016/0952-7915(90)90031-b. [DOI] [PubMed] [Google Scholar]
  27. Mikkelsen T., Yan P. S., Ho K. L., Sameni M., Sloane B. F., Rosenblum M. L. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. J Neurosurg. 1995 Aug;83(2):285–290. doi: 10.3171/jns.1995.83.2.0285. [DOI] [PubMed] [Google Scholar]
  28. Mori M., Kohli A., Baker S. P., Savas L., Fraire A. E. Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: are they useful? Mod Pathol. 1997 Jun;10(6):572–577. [PubMed] [Google Scholar]
  29. Opdenakker G., Van Damme J. Chemotactic factors, passive invasion and metastasis of cancer cells. Immunol Today. 1992 Nov;13(11):463–464. doi: 10.1016/0167-5699(92)90079-M. [DOI] [PubMed] [Google Scholar]
  30. Ozeki Y., Takishima K., Takagi K., Aida S., Tamai S., Mamiya G., Ogata T. Immunohistochemical analysis of cathepsin B expression in human lung adenocarcinoma: the role in cancer progression. Jpn J Cancer Res. 1993 Sep;84(9):972–975. doi: 10.1111/j.1349-7006.1993.tb00187.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Rempel S. A., Rosenblum M. L., Mikkelsen T., Yan P. S., Ellis K. D., Golembieski W. A., Sameni M., Rozhin J., Ziegler G., Sloane B. F. Cathepsin B expression and localization in glioma progression and invasion. Cancer Res. 1994 Dec 1;54(23):6027–6031. [PubMed] [Google Scholar]
  32. Rozhin J., Robinson D., Stevens M. A., Lah T. T., Honn K. V., Ryan R. E., Sloane B. F. Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants. Cancer Res. 1987 Dec 15;47(24 Pt 1):6620–6628. [PubMed] [Google Scholar]
  33. Rozhin J., Sameni M., Ziegler G., Sloane B. F. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res. 1994 Dec 15;54(24):6517–6525. [PubMed] [Google Scholar]
  34. Sedo A., Krepela E., Kasafírek E. Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumors and lung parenchyma. J Cancer Res Clin Oncol. 1991;117(3):249–253. doi: 10.1007/BF01625433. [DOI] [PubMed] [Google Scholar]
  35. Shuja S., Sheahan K., Murnane M. J. Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas. Int J Cancer. 1991 Sep 30;49(3):341–346. doi: 10.1002/ijc.2910490305. [DOI] [PubMed] [Google Scholar]
  36. Sloane B. F., Moin K., Sameni M., Tait L. R., Rozhin J., Ziegler G. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J Cell Sci. 1994 Feb;107(Pt 2):373–384. doi: 10.1242/jcs.107.2.373. [DOI] [PubMed] [Google Scholar]
  37. Sloane B. F., Rozhin J., Hatfield J. S., Crissman J. D., Honn K. V. Plasma membrane-associated cysteine proteinases in human and animal tumors. Exp Cell Biol. 1987;55(4):209–224. doi: 10.1159/000163420. [DOI] [PubMed] [Google Scholar]
  38. Stonelake P. S., Jones C. E., Neoptolemos J. P., Baker P. R. Proteinase inhibitors reduce basement membrane degradation by human breast cancer cell lines. Br J Cancer. 1997;75(7):951–959. doi: 10.1038/bjc.1997.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Strohmaier A. R., Porwol T., Acker H., Spiess E. Tomography of cells by confocal laser scanning microscopy and computer-assisted three-dimensional image reconstruction: localization of cathepsin B in tumor cells penetrating collagen gels in vitro. J Histochem Cytochem. 1997 Jul;45(7):975–983. doi: 10.1177/002215549704500707. [DOI] [PubMed] [Google Scholar]
  40. Sukoh N., Abe S., Nakajima I., Ogura S., Isobe H., Inoue K., Kawakami Y. Immunohistochemical distributions of cathepsin B and basement membrane antigens in human lung adenocarcinoma: association with invasion and metastasis. Virchows Arch. 1994;424(1):33–38. doi: 10.1007/BF00197390. [DOI] [PubMed] [Google Scholar]
  41. Sukoh N., Abe S., Ogura S., Isobe H., Takekawa H., Inoue K., Kawakami Y. Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer. Cancer. 1994 Jul 1;74(1):46–51. doi: 10.1002/1097-0142(19940701)74:1<46::aid-cncr2820740109>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  42. Ulbricht B., Hagmann W., Ebert W., Spiess E. Differential secretion of cathepsins B and L from normal and tumor human lung cells stimulated by 12(S)-hydroxy-eicosatetraenoic acid. Exp Cell Res. 1996 Aug 1;226(2):255–263. doi: 10.1006/excr.1996.0226. [DOI] [PubMed] [Google Scholar]
  43. Werle B., Ebert W., Klein W., Spiess E. Cathepsin B in tumors, normal tissue and isolated cells from the human lung. Anticancer Res. 1994 May-Jun;14(3A):1169–1176. [PubMed] [Google Scholar]
  44. Werle B., Ebert W., Klein W., Spiess E. Charge polymorphism in human lung cell pro-cathepsin B. Anticancer Res. 1996 Jan-Feb;16(1):49–53. [PubMed] [Google Scholar]
  45. Werle B., Jülke B., Lah T., Spiess E., Ebert W. Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung. Br J Cancer. 1997;75(8):1137–1143. doi: 10.1038/bjc.1997.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Yan S., Sameni M., Sloane B. F. Cathepsin B and human tumor progression. Biol Chem. 1998 Feb;379(2):113–123. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES